Answers are grounded in this paper and cite their sources.
Premature ovarian insufficiency (POI) is a multifactorial and heterogeneous condition characterized by secondary amenorrhea, elevated levels of follicle-stimulating hormone (FSH), and decreased levels of estradiol and anti-Müllerian hormone (AMH). The etiology of POI is influenced by genetic, epigenetic, autoimmune, environmental, and other factors. Epigenetic mechanisms, such as DNA methylation, histone modifications, and regulation by non-coding RNAs, play a significant role in the pathogenesis of POI. Hypermethylation of gene promoters (e.g., FOXO3, BMP15, GDF9) and alterations in histone modifications (e.g., H3K9ac, H3K27me3) lead to the suppression of genes involved in oogenesis and folliculogenesis. Non-coding RNAs, including microRNAs (e.g., miR-23a, miR-21) and long non-coding RNAs (e.g., HOTAIR), regulate processes such as apoptosis and oxidative stress in ovarian cells. The study of epigenetic mechanisms opens up new perspectives for the development of personalized approaches to the early diagnosis and treatment of IDD, which is especially important for women with infertility.
No takes yet. Share an insight, caveat, or question.
Adamyan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: